Preferences
Related Series
Related Segments


Patient Privacy Monitoring 2021
Many High-Performing Options for Keeping Records Safe
Current Time Inside Cache Tag Helper: 5/29/2023 9:09:25 AM and Model.reportId = 1690
To combat the rising number of patient privacy breaches, healthcare organizations are increasingly using patient privacy monitoring solutions for regulatory compliance, efficiency, and peace of mind around medical record access. Overall, patient privacy monitoring is one of the highest-scoring markets KLAS measures. For this report, KLAS interviewed 148 healthcare organizations about their customer experience and tracked 48 recent purchase decisions through our Decision Insights† research to learn why certain solutions are being chosen and who can reliably lead organizations to success.† Note: KLAS’ Decision Insights data conveys the future plans of current and potential customers in a given market segment. For more details, see the About This Report section.
if you don't have a login, getting started is easy.
Key Findings:
- Amid Rapid Growth, Maize Analytics & Protenus Maintain Very High Customer Satisfaction
- Market Pioneer Imprivata (FairWarning) Drives New Wins with References & Functionality; Challenges Continue for Customers Not Using Managed Privacy Services
- iatricSystems Largely Selected because of Preexisting Relationships; Technology Not Yet Seen as On Par with Market Leaders
- Solid Options Abound Regardless of Current EMR Vendor; Experiences Vary for Epic & MEDITECH Organizations Using Imprivata (FairWarning)
- Vendors at a Glance

Writer
Amanda Wind Smith

Designer
Jess Wallace-Simpson

Project Manager
Natalie Jamison
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.